Bodal Chemicals Future Growth
Future criteria checks 4/6
Bodal Chemicals is forecast to grow earnings and revenue by 92.5% and 15.8% per annum respectively. EPS is expected to grow by 93.4% per annum. Return on equity is forecast to be 6.9% in 3 years.
Key information
92.5%
Earnings growth rate
93.4%
EPS growth rate
| Chemicals earnings growth | 23.0% |
| Revenue growth rate | 15.8% |
| Future return on equity | 6.9% |
| Analyst coverage | Low |
| Last updated | 29 Nov 2024 |
Recent future growth updates
Recent updates
We Think Shareholders May Want To Consider A Review Of Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Package
Sep 18
When Should You Buy Bodal Chemicals Limited (NSE:BODALCHEM)?
Apr 04Need To Know: This Analyst Just Made A Substantial Cut To Their Bodal Chemicals Limited (NSE:BODALCHEM) Estimates
Aug 18Increases to Bodal Chemicals Limited's (NSE:BODALCHEM) CEO Compensation Might Cool off for now
Sep 20Bodal Chemicals' (NSE:BODALCHEM) Dividend Will Be ₹0.80
Sep 04Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jul 23Is Bodal Chemicals (NSE:BODALCHEM) A Risky Investment?
Jan 13Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Jul 18Should You Investigate Bodal Chemicals Limited (NSE:BODALCHEM) At ₹95.80?
Apr 08Bodal Chemicals Limited's (NSE:BODALCHEM) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Mar 21These 4 Measures Indicate That Bodal Chemicals (NSE:BODALCHEM) Is Using Debt Extensively
Mar 06How Is Bodal Chemicals' (NSE:BODALCHEM) CEO Compensated?
Feb 19Is Bodal Chemicals Limited (NSE:BODALCHEM) A Great Dividend Stock?
Feb 06
What Percentage Of Bodal Chemicals Limited (NSE:BODALCHEM) Shares Do Insiders Own?
Jan 22Would Shareholders Who Purchased Bodal Chemicals' (NSE:BODALCHEM) Stock Three Years Be Happy With The Share price Today?
Jan 06Are Insiders Buying Bodal Chemicals Limited (NSE:BODALCHEM) Stock?
Dec 22Bodal Chemicals Limited (NSE:BODALCHEM) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Dec 07Here's Why Bodal Chemicals (NSE:BODALCHEM) Has A Meaningful Debt Burden
Nov 22Is Bodal Chemicals Limited (NSE:BODALCHEM) A Strong Dividend Stock?
Nov 07Is Bodal Chemicals (NSE:BODALCHEM) Likely To Turn Things Around?
Oct 13What You Need To Know About Bodal Chemicals Limited's (NSE:BODALCHEM) Investor Composition
Sep 25Who Has Been Buying Bodal Chemicals Limited (NSE:BODALCHEM) Shares?
Sep 09If You Had Bought Bodal Chemicals (NSE:BODALCHEM) Stock Five Years Ago, You Could Pocket A 144% Gain Today
Aug 25Bodal Chemicals (NSE:BODALCHEM) Has A Somewhat Strained Balance Sheet
Aug 10What Did Bodal Chemicals' (NSE:BODALCHEM) CEO Take Home Last Year?
Aug 10Should Bodal Chemicals Limited (NSE:BODALCHEM) Be Part Of Your Income Portfolio?
Jul 29Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 22,803 | 934 | 730 | 1,721 | 1 |
| 3/31/2026 | 20,506 | 570 | 477 | 1,630 | 2 |
| 3/31/2025 | 16,669 | 126 | 620 | 1,435 | 2 |
| 9/30/2024 | 15,827 | 16 | 937 | 2,131 | N/A |
| 6/30/2024 | 14,841 | 31 | N/A | N/A | N/A |
| 3/31/2024 | 13,946 | 65 | -407 | 2,042 | N/A |
| 12/31/2023 | 13,906 | 72 | N/A | N/A | N/A |
| 9/30/2023 | 13,821 | 87 | -348 | 2,192 | N/A |
| 6/30/2023 | 14,440 | 177 | N/A | N/A | N/A |
| 3/31/2023 | 15,743 | 380 | -479 | 2,899 | N/A |
| 12/31/2022 | 17,678 | 676 | N/A | N/A | N/A |
| 9/30/2022 | 20,138 | 896 | -2,157 | 1,101 | N/A |
| 6/30/2022 | 20,878 | 1,030 | N/A | N/A | N/A |
| 3/31/2022 | 20,553 | 1,042 | -1,726 | -135 | N/A |
| 12/31/2021 | 18,861 | 1,004 | N/A | N/A | N/A |
| 9/30/2021 | 16,904 | 1,052 | -2,713 | -355 | N/A |
| 6/30/2021 | 15,304 | 916 | N/A | N/A | N/A |
| 3/31/2021 | 12,264 | 420 | -1,911 | -130 | N/A |
| 12/31/2020 | 11,622 | 418 | N/A | N/A | N/A |
| 9/30/2020 | 11,224 | 297 | 677 | 1,198 | N/A |
| 6/30/2020 | 11,204 | 406 | N/A | N/A | N/A |
| 3/31/2020 | 13,748 | 872 | -425 | 96 | N/A |
| 12/31/2019 | 13,506 | 941 | N/A | N/A | N/A |
| 9/30/2019 | 13,586 | 1,091 | -1,367 | 115 | N/A |
| 6/30/2019 | 14,441 | 1,323 | N/A | N/A | N/A |
| 3/31/2019 | 14,235 | 1,432 | 377 | 1,860 | N/A |
| 12/31/2018 | 13,725 | 1,528 | N/A | N/A | N/A |
| 9/30/2018 | 13,454 | 1,527 | N/A | N/A | N/A |
| 6/30/2018 | 12,083 | 1,321 | N/A | N/A | N/A |
| 3/31/2018 | 11,422 | 1,226 | N/A | 71 | N/A |
| 3/31/2017 | 12,344 | 1,329 | N/A | 1,036 | N/A |
| 3/31/2016 | 9,078 | 860 | N/A | 1,312 | N/A |
| 3/31/2015 | 10,443 | 918 | N/A | 1,977 | N/A |
| 3/31/2014 | 9,496 | 302 | N/A | 492 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BODALCHEM's forecast earnings growth (92.5% per year) is above the savings rate (6.7%).
Earnings vs Market: BODALCHEM's earnings (92.5% per year) are forecast to grow faster than the Indian market (18.1% per year).
High Growth Earnings: BODALCHEM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BODALCHEM's revenue (15.8% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: BODALCHEM's revenue (15.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BODALCHEM's Return on Equity is forecast to be low in 3 years time (6.9%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 18:07 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bodal Chemicals Limited is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nikhil Shetty | BP Wealth Management Private Limited |
| Anil Burra | FirstCall Research |
| Chirag Shah | ICICIdirect.com |